Skip to main content
SpringerLink
Log in

Male Breast Cancer

  • Chapter
  • First Online:
Book cover Breast Disease

  • 853 Accesses

Abstract

Breast cancer is observed in men 100-fold less often than in women. The risk of breast cancer in men is approximately 1 in 1000 throughout life. The American Association of Cancer predicted that 2360 men would be diagnosed with breast cancer in 2014 and that 430 male patients with breast cancer would die. The mean age of diagnosis of male breast cancer (MBC) is 67.7, which is 5–10 years older than for female breast cancer (FBC) patients in the USA, but in other parts of the world, such as the Middle East and South Asia, the age gap is smaller. Previous studies have shown that MBC cases are significantly different from female cases, whereas new studies have reported that breast cancer has similar characteristics at the same stages in both genders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  2. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2012;62(4):220–41.

    Article  PubMed  Google Scholar 

  3. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2014.

    Google Scholar 

  4. American Cancer Society. Cancer facts and figures 2018. Atlanta: American Cancer Society; 2018. Available online. Last accessed 27 Apr 2018.

    Google Scholar 

  5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. CA Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  6. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.

    Article  PubMed  Google Scholar 

  7. Nirmul D, Pegoraro RJ, Jialal I, Naidoo C, Joubert SM. The sex hormone profile of male patient with breast cancer. Br J Cancer. 1983;48(3):423–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sanchez AG, Villanueva AG, Redondo C. Lobular carcinoma of the breast in a patient with Klinefelter’s syndrome. A case with bilateral, synchronous, histologically different breast tumors. Cancer. 1986;57(6):1181–3.

    Article  CAS  PubMed  Google Scholar 

  9. Schuchardt U, Seegenschmiedt MH, Kirschner MJ, Renner H, Sauer R. Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Am J Clin Oncol. 1996;19(4):330–6.

    Article  CAS  PubMed  Google Scholar 

  10. Gradishar WJ. Male breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Disease of the breast. Philadelphia: Lippincott Williams and Wilkins; 2000. p. 661–7.

    Google Scholar 

  11. Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232–9.

    Article  PubMed  Google Scholar 

  12. Crichlow RW, Galt SW. Male breast cancer. Surg Clin N Am. 1990;70(5):1165–77.

    Article  CAS  PubMed  Google Scholar 

  13. Salehi A, Zeraati H, Mohammad K, Mahmoudi M, Talei AR, Ghaderi A, et al. Survival of male breast cancer in Fars, South of Iran. Iran Red Crescent Med J. 2011;13(2):99–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Tawil AN, Boulos FI, Chakhachiro ZI, Otrock ZK, Kandaharian L, El Saghir NS, et al. Clinicopathologic and immunohistochemical characteristics of male breast cancer: a single center experience. Breast J. 2012;18(1):65–8.

    Article  PubMed  Google Scholar 

  15. Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Breast J Cancer. 1992;65:252–4.

    CAS  Google Scholar 

  16. Johansen Taber KA, Morisy LR, Osbahr AJ 3rd, Dickinson BD. Male breast cancer: risk factors, diagnosis, and management (review). Oncol Rep. 2010;24(5):1115–20. Review

    Article  PubMed  Google Scholar 

  17. Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Larønningen S, et al. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011;29(33):4381–6.

    Article  PubMed  Google Scholar 

  18. Gómez-Raposo C, Zambrana Tévar F, Sereno Moyano M, López Gómez M, Casado E. Male breast cancer. Cancer Treat Rev. 2010;36(6):451–7.

    Article  PubMed  Google Scholar 

  19. Volpe CM, Raffetto JD, Collure DW, Hoover EL, Doerr RJ. Unilateral male breast masses: cancer risk and their evaluation and management. Am Surg. 1999;65(3):250–3.

    CAS  PubMed  Google Scholar 

  20. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, et al. Population-based study of risk of breast cancer in carriers of BRCA-2 mutation. Lancet. 1998;352(9137):1337–9.

    Article  CAS  PubMed  Google Scholar 

  21. Satram-Hoang S, Moran EM, Anton-Culver H, Burras RW, Heimann TM, Boggio I, et al. A pilot study of male breast cancer in the Veterans Affairs healthcare system. J Environ Pathol Toxicol Oncol. 2010;29(3):235–44.

    Article  PubMed  Google Scholar 

  22. Winer EP, Morrow M, Osborne CK, Harris JR. Malignant tumors of the breast. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1651–717.

    Google Scholar 

  23. Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28(12):2114–22.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marger D, Urdaneta N, Fischer JJ. Breast cancer in brothers: case reports and review of 30 cases of male breast cancer. Cancer. 1975;36(2):458–61.

    Article  CAS  PubMed  Google Scholar 

  25. Basham VM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res BCR. 2002;4(1):R2.

    Article  CAS  PubMed  Google Scholar 

  26. Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, et al. Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. Breast Dis. 2011;33(1):17–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bishop DT. BRCA1 and BRCA2 and breast cancer incidence: a review. Ann Oncol. 1999;10(Suppl 6):113–9.

    Article  PubMed  Google Scholar 

  28. Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F. Risk of breast cancer in male BRCA2 carriers. J Med Genet. 2010;47(10):710–1.

    Article  CAS  PubMed  Google Scholar 

  29. Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, et al. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. Breast Cancer Res Treat. 2012;134(1):411–8.

    Article  CAS  PubMed  Google Scholar 

  30. Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL. Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat. 2011;126(3):771–8.

    Article  CAS  PubMed  Google Scholar 

  31. Blanco A, de la Hoya M, Balmana J, y Cajal TR, Teulé A, Miramar MD, et al. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res Treat. 2012;132(1):307–15.

    Article  PubMed  Google Scholar 

  32. Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, et al. Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients. Breast Cancer Res Treat. 2011;129(2):575–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Silvestri V, Rizzolo P, Zanna I, Falchetti M, Masala G, Bianchi S, et al. PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat. 2010;122(1):299–301.

    Article  PubMed  Google Scholar 

  34. Sauty de Chalon A, Teo Z, Park DJ, Odefrey FA, kConFab HJL, Southey MC. Are PALB2 mutations associated with increased risk of male breast cancer? Breast Cancer Res Treat. 2010;121(1):253–5.

    Article  CAS  PubMed  Google Scholar 

  35. Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Bianchi S, et al. Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy. Breast Cancer Res Treat. 2011;126(2):539–43.

    Article  PubMed  Google Scholar 

  36. Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Palli D, et al. Mutation screening of RAD51C in male breast cancer patients. Breast Cancer Res. 2011;13(1):404.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kizildag S, Gulsu E, Bagci O, Yuksel E, Canda T. Vitamin D receptor gene polymorphisms and male breast cancer risk in Turkish population. J BUON. 2011;16(4):640–5.

    CAS  PubMed  Google Scholar 

  38. Fentiman IS, Fourguet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595–604.

    Article  PubMed  Google Scholar 

  39. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10(7):471–9.

    Article  PubMed  Google Scholar 

  40. Ottini L, Masala G, D’Amico C, Mancini B, Saieva C, Aceto G, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res. 2003;63:342–7.

    CAS  PubMed  Google Scholar 

  41. Donegan WL, Redlich PN. Breast cancer in men. Surg Clin N Am. 1996;76(2):343–63.

    Article  CAS  PubMed  Google Scholar 

  42. Brinton LA. Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr. 2011;100(6):814–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Male breast cancer. Crit Rev Oncol Hematol. 2010;73:141–55.

    Article  PubMed  Google Scholar 

  44. Evans DB, Crichlow RW. Carcinoma of the male breast and Klinefelter’s syndrome: is there an association? CA Cancer J Clin. 1987;37(4):246–51.

    Article  CAS  PubMed  Google Scholar 

  45. Heller K, Rosen P, Schottenfeld D. Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg. 1978;188:60–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Green L, Wysowski DK, Fourcroy JL. Gynecomastia and breast cancer during finasteride therapy. N Engl J Med. 1996;335(11):823.

    Article  CAS  PubMed  Google Scholar 

  47. Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014;106(3):djt465.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Rohrmann S, Shiels MS, Lopez DS, Rifai N, Nelson WG, Kanarek N, et al. Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control. 2011;22(8):1141–51.

    Article  PubMed  Google Scholar 

  49. Moore MP, Harris RH, Lippman ME, Morrow M, Hellman S. Male breast cancer. diseases of the breast. 1st ed. Philadelphia: Lippincott-Raven; 1996. p. 859–63.

    Google Scholar 

  50. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Epidemiology of male breast cancer: a meta analysis published case-control studies and discussion of selected a etiological factors. Int J Cancer. 1993;53(4):538–49.

    Article  CAS  PubMed  Google Scholar 

  51. Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 2010;119(1):185–92.

    Article  PubMed  Google Scholar 

  52. Eldar S, Nash E, Abrahanson J. Radiation carcinogenesis in the male breast. Eur J Surg Oncol. 1989;15(3):274–8.

    CAS  PubMed  Google Scholar 

  53. Villeneuve S, Cyr D, Lynge E, Orsi L, Sabroe S, Merletti F, et al. Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med. 2010;67(12):837–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med. 2000;37(4):349–52.

    Article  CAS  PubMed  Google Scholar 

  55. Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A. Risk factors for male breast cancer a case-control study from Scandinavia. Acta Oncol. 2001;40(4):467–71.

    Article  CAS  PubMed  Google Scholar 

  56. Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, et al. Current management of male breast cancer: a review of 104 cases. Ann Surg. 1992;215(5):451–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males. A multi institutional survey. Cancer. 1998;83(3):498–509.

    Article  CAS  PubMed  Google Scholar 

  58. Bezwoda WR, Hesdorffer C, Dansey R, de Moor N, Derman DP, Browde S, et al. Breast cancer in men: clinical features, hormone receptor status, and response to therapy. Cancer. 1987;60(6):1337–40.

    Article  CAS  PubMed  Google Scholar 

  59. Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24(6):1434–43.

    Article  CAS  PubMed  Google Scholar 

  60. Xia LP, Zhou FF, Guo GF, Wang F, Wang X, Yuan ZY, et al. Chinese female breast cancer patients show a better overall survival than their male counterparts. Chin Med J. 2010;123(17):2347–52.

    PubMed  Google Scholar 

  61. Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to instage migration. Ann Surg Oncol. 2011;18(7):1837–44.

    Article  PubMed  Google Scholar 

  62. Bourhafour M, Belbaraka R, Souadka A, M’rabti H, Tijami F, Errihani H. Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Res Notes. 2011;4:219.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Wauters CAP, Kooistra BW, de Kievit-van der Heijden IM, Strobbe LJ. Is cytology useful in the diagnostic workup of male breast lesions? A retrospective study over a 16-year period and review of the recent literature. Acta Cytol. 2010;54:259–64.

    Article  PubMed  Google Scholar 

  64. Doyle S, Steel J, Porter G. Imaging male breast cancer. Clin Radiol. 2011;66:1079–85.

    Article  CAS  PubMed  Google Scholar 

  65. Jackson VP, Gilmor RL. Male breast carcinoma and gynecomastia: comparison of mammography with sonography. Radiology. 1983;149(2):533–6.

    Article  CAS  PubMed  Google Scholar 

  66. Kapdi CC, Parekh NJ. The male breast. Radiol Clin N Am. 1983;21(1):137–48.

    CAS  PubMed  Google Scholar 

  67. Evans GF, Anthony T, Turnage RH. The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg. 2001;181(2):96–100.

    Article  CAS  PubMed  Google Scholar 

  68. Bhagat P, Kline TS. The male breast and malignant neoplasms. Diagnosis by aspiration biopsy cytology. Cancer. 1990;65(10):2338–41.

    Article  CAS  PubMed  Google Scholar 

  69. Gill MS, Kayani N, Khan MN, Hasan SH. Breast diseases in males a morphological review of 150 cases. J Pak Med Assoc. 2000;50(6):177–9.

    CAS  PubMed  Google Scholar 

  70. Tahmasebi S, Akrami M, Omidvari S, Salehi A, Talei A. Male breast cancer; analysis of 58 cases in Shiraz, South of Iran. Breast Dis. 2010;31(1):29–32.

    Article  PubMed  Google Scholar 

  71. Arslan UY, Oksuzoglu B, Ozdemir N, Aksoy S, Alkış N, Gök A, et al. Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol. 2012;29(2):554–60.

    Article  PubMed  Google Scholar 

  72. Liukkonen S, Saarto T, Maenpaa H, Sjöström-Mattson J. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981–2006. Acta Oncol. 2010;49(3):322–7.

    Article  PubMed  Google Scholar 

  73. Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, et al. Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol. 2013;24(Suppl 8):viii75–82.

    Article  PubMed  Google Scholar 

  74. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Molecular markers in male breast carcinoma. Cancer. 1998;83(9):1947–55.

    Article  CAS  PubMed  Google Scholar 

  75. Kanthan R, Fried I, Rueckl T, Senger JL, Kanthan SC. Expression of cell cycle proteins in male breast carcinoma. World J Surg Oncol. 2010;8:10.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, et al. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29(2):405–17.

    CAS  PubMed  Google Scholar 

  77. Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, Dent J, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2012;133(3):949–58.

    Article  CAS  PubMed  Google Scholar 

  78. Zhou FF, Xia LP, Guo GF, Wang X, Yuan ZY, Zhang B, et al. Changes in therapeutic strategies in Chinese male patients with breast cancer: 40 years of experience in a single institute. Breast. 2010;19(6):450–5.

    Article  PubMed  Google Scholar 

  79. Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, et al. Male breast cancer: management and follow-up recommendations. Breast J. 2011;17(5):503–9.

    Article  PubMed  Google Scholar 

  80. Cloyd JM, Hernandez-Boussard T, Wapnir IL. Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009. Ann Surg Oncol. 2013;20(5):1545–50.

    Article  PubMed  Google Scholar 

  81. Elmi M, Sequeira S, Azin A, Elnahas A, McCready DR, Cil TD. Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Breast Cancer Res Treat. 2018; https://doi.org/10.1007/s10549-018-4830-y.

    Article  PubMed  Google Scholar 

  82. Fogh S, Kachnic LA, Goldberg SI, Taghian AG, Powell SN, Hirsch AE. Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Clin Breast Cancer. 2013;13(5):344–9.

    Article  PubMed  Google Scholar 

  83. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561–4.

    Article  Google Scholar 

  84. Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA. Carcinoma of the male breast. Ann Intern Med. 1992;117(9):771–7.

    Article  CAS  PubMed  Google Scholar 

  85. Bagley CS, Wesley MN, Young RC, Lippman ME. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol. 1987;10(1):55–60.

    Article  CAS  PubMed  Google Scholar 

  86. Patel HZ 2nd, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer. 1989;64(8):1583–5.

    Article  PubMed  Google Scholar 

  87. Fogh S, Hirsch AE, Langmead JP, Goldberg SI, Rosenberg CL, Taghian AG, et al. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer. 2011;11(1):39–45.

    Article  CAS  PubMed  Google Scholar 

  88. Zhou FF, Xia LP, Wang X, Guo GF, Rong YM, Qiu HJ, et al. Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution. Chin J Cancer. 2010;29(2):184–8.

    Article  PubMed  Google Scholar 

  89. Visram H, Kanji F, Dent SF. Endocrine therapy for male breast cancer: rates of toxicity and adherence. Curr Oncol. 2010;17(5):17–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol. 2012;23(6):1471–4.

    Article  CAS  PubMed  Google Scholar 

  91. Anelli TF, Anelli A, Tran KN, Lebwohl DE, Borgen PI. Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer. 1994;74(1):74–7.

    Article  CAS  PubMed  Google Scholar 

  92. Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, Röhl FW, et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat. 2013;137(2):465–70.

    Article  CAS  PubMed  Google Scholar 

  93. Abrams MJ, Koffer PP, Wazer DE, Hepel JT. Postmastectomy radiation therapy is associated with improved survival in node-positive male breast cancer: a population analysis. Int J Radiat Oncol Biol Phys. 2017;98(2):384–91.

    Article  PubMed  Google Scholar 

  94. Yu E, Suzuki H, Younus J, Elfiki T, Stitt L, Yau G, et al. The impact of post-mastectomy radiation therapy on male breast cancer patients—a case series. Int J Radiat Oncol Biol Phys. 2012;82(2):696–700.

    Article  PubMed  Google Scholar 

  95. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337(14):949–55.

    Article  CAS  Google Scholar 

  96. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med. 1997;337(14):956–62.

    Article  CAS  Google Scholar 

  97. Erlichman C, Murphy KC, Elhakim T. Male breast cancer: a 13-year review of 89 patients. J Clin Oncol. 1984;2(8):903–9.

    Article  CAS  PubMed  Google Scholar 

  98. Patel JK, Nemoto T, Dao TL. Metastatic breast cancer in males. Assessment of endocrine therapy. Cancer. 1984;53(6):1344–6.

    Article  CAS  PubMed  Google Scholar 

  99. Donegan WL. Cancer of the male breast. In: Donegan WL, Spratt JS, editors. Cancer of the breast. Philadelphia: WB Saunders; 1995. p. 774–5.

    Google Scholar 

  100. Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol. 2002;25(3):235–7.

    Article  PubMed  Google Scholar 

  101. Mauras N, O’Brien KO, Klein KO, Hayes V. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab. 2000;85(7):2370–7.

    CAS  PubMed  Google Scholar 

  102. Zabolotny BP, Zalai CV, Meterissian SH. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol. 2005;90(1):26–30.

    Article  PubMed  Google Scholar 

  103. Italiano A, Largillier R, Marcy PY, Foa C, Ferrero JM, Hartmann MT, et al. Complete remission obtained with letrozole in a man with metastatic breast cancer. Rev Med Interne. 2004;25(4):323–4.

    Article  CAS  PubMed  Google Scholar 

  104. Labrie F, Dupont A, Belanger A, Lacourcière Y, Béland L, Cusan L, et al. Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report. Clin Invest Med. 1990;13(5):275–8.

    CAS  PubMed  Google Scholar 

  105. Lopez M, Natali M, Di Lauro L, Vici P, Pignatti F, Carpano S. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer. 1993;72(2):502–5.

    Article  CAS  PubMed  Google Scholar 

  106. Doberauer C, Niederle N, Schmidt CG. Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide. Cancer. 1988;62(3):474–8.

    Article  CAS  PubMed  Google Scholar 

  107. Chen X, Liu X, Zhang L, Li S, Shi Y, Tong Z. Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences. Jpn J Clin Oncol. 2013;43(10):954–63.

    Article  PubMed  Google Scholar 

  108. Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol. 2010;73(3):246–54.

    Article  CAS  PubMed  Google Scholar 

  109. Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77(3):490–8.

    Article  CAS  PubMed  Google Scholar 

  110. Donegan WL. Cancer of the male breast. J Gend Specif Med. 2000;3(4):55–8.

    CAS  PubMed  Google Scholar 

  111. Foerster R, Foerster FG, Wulff V, Schubotz B, Baaske D, Wolfgarten M, et al. Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. BMC Cancer. 2011;11:335.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Tural D, Selcukbiricik F, Aydogan F, Beşe N, Yetmen O, Ilvan Ş, et al. Male breast cancers behave differently in elderly patients. Jpn J Clin Oncol. 2013;43(1):22–7.

    Article  PubMed  Google Scholar 

  113. Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, Peter Z, et al. The prognosis of breast cancer in males: a report of 335 cases. Cancer. 1993;71(1):154–61.

    Article  CAS  PubMed  Google Scholar 

  114. Soliman AA, Denewer AT, El-Sadda W, Abdel-Aty AH, Refky B. A retrospective analysis of survival and prognostic factors of male breast cancer from a single center. BMC Cancer. 2014;14:227.

    Article  PubMed  PubMed Central  Google Scholar 

  115. O’Malley CD, Prehn AW, Shema SJ, Glaser SL. Racial/ethnic differences in survival rates in a population-based series of men with breast carcinoma. Cancer. 2002;94(11):2836–43.

    Article  PubMed  Google Scholar 

  116. Selcukbiricik F, Tural D, Aydogan F, Beşe N, Büyükünal E, Serdengeçti S, et al. Male breast cancer: 37-year data study at a single experience center in Turkey. J Breast Cancer. 2013;16(1):60–5.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Xia Q, Shi YX, Liu DG, Jiang WQ. Clinicopathological characteristics of male breast cancer: analysis of 25 cases at a single institution [in Chinese with English abstract]. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:1469–73.

    PubMed  Google Scholar 

  118. Andre S, Fonseca I, Pinto AE, Cardoso P, Pereira T, Soares J, et al. Male breast cancer-a reappraisal of clinical and biologic indicators of prognosis. Acta Oncol. 2001;40(4):472–8.

    Article  CAS  PubMed  Google Scholar 

  119. Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, et al. Quality of life and symptoms in male breast cancer survivors. Breast. 2013;22(2):197–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Abdullah Igci

  2. Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Mustafa Tukenmez & Enver Özkurt

Authors
  1. Abdullah Igci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mustafa Tukenmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enver Özkurt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdullah Igci .

Editor information

Editors and Affiliations

  1. Oncology Institute, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Adnan Aydiner

  2. Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Abdullah Igci

  3. Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Magee-Women’s Hospital of UPMC, Pittsburgh, PA, USA

    Atilla Soran

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Igci, A., Tukenmez, M., Özkurt, E. (2019). Male Breast Cancer. In: Aydiner, A., Igci, A., Soran, A. (eds) Breast Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-16792-9_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16792-9_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16791-2

  • Online ISBN: 978-3-030-16792-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation